Status
Conditions
Treatments
About
This study is investigating the hypothesis that alpha-gal is responsible for the gastrointestinal symptoms that occur in some alpha-gal syndrome subjects following the consumption of mammalian meat. This will be tested by comparing symptoms and immune responses in subjects with alpha-gal syndrome following consumption of "wild-type" pork (which contains alpha-gal) versus consumption of a novel pork product which has been genetically modified to lack alpha-gal (GalSafe pork from Revivicor Inc.).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Alpha-gal cases:
Control subjects:
Exclusion criteria
Alpha-gal cases:
Control subjects:
Primary purpose
Allocation
Interventional model
Masking
Loading...
Central trial contact
Jeffrey Wilson, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal